BSECompany Update13 Aug 2026 · 13 Aug 2026, 04:51 pm
Filing of Application for Reclassification with Stock Exchanges
Sun Pharma Advanced Research Company Ltd · 532872
✦ AI SummaryPromoter Reclassif.
Sun Pharma Advanced Research Company Ltd has filed an application with the stock exchanges seeking reclassification from the 'Promoter Group' category to 'Public' category, as per SEBI regulations.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk2/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Sun Pharma Advanced Research Company Ltd - 532872 - Filing Of Application For Reclassification With Stock Exchanges
Attachments (1)
📄pdf
Download →
c25d28dd-35e4-4274-8e3b-e2b2efacdab7.pdf
View document text
SPARC/Sec/SE/2026-27/30 August 13, 2026
National Stock Exchange of India Ltd., BSE Limited,
Exchange Plaza, 5th Floor, Market Operations Dept.
Plot No. C/1, G Block, P. J. Towers,
Bandra Kurla Complex, Dalal Street,
Bandra (East), Mumbai – 400 051. Mumbai - 400 001.
Scrip Symbol: SPARC Scrip Code: 532872
Dear Sir/Madam,
Intimation under Regulation 30 and Regulation 31A of SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015 – Filing of application for reclassification with
stock exchanges
Further to our earlier intimations dated July 27, 2026 and August 10, 2026 this is to inform that
the Company has submitted an application today, i.e., August 13, 2026, with the stock exchanges
seeking their no objection/approval for the reclassification from the ‘Promoter Group’ category
to ‘Public’ category, in accordance with Regulation 31A of the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015 (“Listing Regulations”).
This intimation is being made in compliance with the provisions of the Listing Regulations.
For Sun Pharma Advanced Research Company Ltd.
Kajal Damania
Company Secretary and Compliance Officer